IMMUNOGENICITY OF COMBINED ANTI-HIV AND ANTISUPPRESSIVE VACCINE PREPARATIONS

被引:12
作者
CARELLI, C
HALBREICH, A
BERNARD, J
BIZZINI, B
ACHOUR, A
ZAGURY, JF
LEBON, P
POLLIOTTI, B
FOLGHERA, S
LAAROUBI, K
ABOUDPIRAK, E
LOWELL, G
BURNY, A
PICARD, O
ZAGURY, D
机构
[1] UNIV PARIS 06,PHYSIOL CELLULAIRE LAB,F-75230 PARIS 05,FRANCE
[2] INST JEAN GODINOI,IMMUNOL LAB,F-51056 REIMS,FRANCE
[3] INST PASTEUR,F-75724 PARIS 15,FRANCE
[4] HOP ST VINCENT DE PAUL,F-75674 PARIS 14,FRANCE
[5] WEIZMANN INST SCI,IL-76100 REHOVOT,ISRAEL
[6] WALTER REED ARMY MED CTR,USA,RES UNIT ISRAEL,WASHINGTON,DC 20307
[7] UNIV LIBRE BRUXELLES,B-1050 BRUSSELS,BELGIUM
[8] HOP ST ANTOINE,F-75571 PARIS 12,FRANCE
关键词
HIV-1; VACCINE; IMMUNOSUPPRESSION; PEPTIDES;
D O I
10.1016/0753-3322(92)90022-Y
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
HIV-1 antigens generate in man both a humoral and cellular immune reaction. However, in ARC/AIDS patients, the cellular response is inhibited by HIV-1 which induces an antiproliferative (suppressive) effect on activated T cells. To overcome this inhibition and up-regulate the cellular response, we designed a new vaccine strategy directed both against HIV-1 and immunosuppression and we used an immunizing preparation composed of HIV-1 antigens combined with immunoregulatory peptides prepared in a biologically inactivated but immunogenic form. In mice, this preparation induced anti-HIV-1 antibodies and a cell-mediated cytotoxicity directed against H2 restricted cells carrying HIV-1 antigens.
引用
收藏
页码:149 / 153
页数:5
相关论文
共 12 条
[1]   HGP-30, A SYNTHETIC ANALOG OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) P17, IS A TARGET FOR CYTOTOXIC LYMPHOCYTES IN HIV-INFECTED INDIVIDUALS [J].
ACHOUR, A ;
PICARD, O ;
ZAGURY, D ;
SARIN, PS ;
GALLO, RC ;
NAYLOR, PH ;
GOLDSTEIN, AL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (18) :7045-7049
[2]   GROUP-SPECIFIC, MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I-RESTRICTED CYTO-TOXIC RESPONSES TO HUMAN IMMUNODEFICIENCY VIRUS-1 (HIV-1) ENVELOPE PROTEINS BY CLONED PERIPHERAL-BLOOD T-CELLS FROM AN HIV-1-INFECTED INDIVIDUAL [J].
KOENIG, S ;
EARL, P ;
POWELL, D ;
PANTALEO, G ;
MERLI, S ;
MOSS, B ;
FAUCI, AS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (22) :8638-8642
[3]   DEVELOPMENT AND TESTING OF AIDS VACCINES [J].
KOFF, WC ;
HOTH, DF .
SCIENCE, 1988, 241 (4864) :426-432
[4]  
LAURENCE J, 1985, SCI AM, V253, P70
[5]   PEPTIDES BOUND TO PROTEOSOMES VIA HYDROPHOBIC FEET BECOME HIGHLY IMMUNOGENIC WITHOUT ADJUVANTS [J].
LOWELL, GH ;
SMITH, LF ;
SEID, RC ;
ZOLLINGER, WD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (02) :658-663
[6]   COMPLEMENTARY-DNA SEQUENCES OF OVARIAN FOLLICULAR-FLUID INHIBIN SHOW PRECURSOR STRUCTURE AND HOMOLOGY WITH TRANSFORMING GROWTH FACTOR-BETA [J].
MASON, AJ ;
HAYFLICK, JS ;
LING, N ;
ESCH, F ;
UENO, N ;
YING, SY ;
GUILLEMIN, R ;
NIALL, H ;
SEEBURG, PH .
NATURE, 1985, 318 (6047) :659-663
[7]   AIDS VACCINE THERAPY - PHASE-I TRIAL [J].
PICARD, O ;
GIRAL, P ;
DEFER, MC ;
FOUCHARD, M ;
MOREL, M ;
MEYOHAS, MC ;
LEBAS, J ;
IMBERT, JC ;
FROTTIER, J ;
SALAUN, JJ ;
LURHUMA, Z ;
MOSS, B ;
GALLO, RC ;
ZAGURY, D .
LANCET, 1990, 336 (8708) :179-179
[8]  
PICARD O, 1992, IN PRESS J AIDS
[9]   AN IMMUNODOMINANT EPITOPE OF THE HUMAN IMMUNODEFICIENCY VIRUS ENVELOPE GLYCOPROTEIN GP160 RECOGNIZED BY CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE-RESTRICTED MURINE CYTO-TOXIC LYMPHOCYTES-T [J].
TAKAHASHI, H ;
COHEN, J ;
HOSMALIN, A ;
CEASE, KB ;
HOUGHTEN, R ;
CORNETTE, JL ;
DELISI, C ;
MOSS, B ;
GERMAIN, RN ;
BERZOFSKY, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (09) :3105-3109
[10]   A GROUP-SPECIFIC ANAMNESTIC IMMUNE-REACTION AGAINST HIV-1 INDUCED BY A CANDIDATE VACCINE AGAINST AIDS [J].
ZAGURY, D ;
BERNARD, J ;
CHEYNIER, R ;
DESPORTES, I ;
LEONARD, R ;
FOUCHARD, M ;
REVEIL, B ;
ITTELE, D ;
LURHUMA, Z ;
MBAYO, K ;
WANE, J ;
SALAUN, JJ ;
GOUSSARD, B ;
DECHAZAL, L ;
BURNY, A ;
NARA, P ;
GALLO, RC .
NATURE, 1988, 332 (6166) :728-731